REM-422

DB19304InvestigationalSmall molecule

REM-422 is an orally bioavailable, small molecule mRNA degrader of the proto-oncogene c-Myb.

Also known as
c-Myb mRNA degrader REM-422 · Myb mRNA degrader REM-422 · Myb mRNA inhibitor REM-422
Code names
REM-422

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of REM-422, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In